For every 25 patients treated with tocilizumab, along with a cheap steroid already routinely given, an additional life would be saved, NHS doctors have said elsewhere.
As well as improving survival and recovery time, it can avoid patients needing to be moved to intensive care, said the NHS doctors.
Patient testimony from Wendy Coleman, 62, attests to the promise of tocilizumab in treating those severely ill with COVID-19.
As the BBC reported, Coleman received the treatment last year when she was admitted to Chesterfield Royal Hospital with severe COVID-19.